J. Safra Sarasin Holding AG Takes $1.04 Million Position in The Clorox Company (NYSE:CLX)

by · The Markets Daily

J. Safra Sarasin Holding AG acquired a new position in shares of The Clorox Company (NYSE:CLX – Free Report) in the fourth quarter, HoldingsChannel.com reports. The institutional investor acquired 6,385 shares of the company’s stock, valued at approximately $1,037,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of CLX. Integral Investment Advisors Inc. grew its stake in shares of Clorox by 4.1% during the 4th quarter. Integral Investment Advisors Inc. now owns 1,718 shares of the company’s stock worth $279,000 after acquiring an additional 67 shares in the last quarter. HCR Wealth Advisors boosted its holdings in Clorox by 1.0% during the fourth quarter. HCR Wealth Advisors now owns 6,870 shares of the company’s stock worth $1,116,000 after purchasing an additional 68 shares during the last quarter. Sound View Wealth Advisors Group LLC grew its position in Clorox by 6.1% in the fourth quarter. Sound View Wealth Advisors Group LLC now owns 1,345 shares of the company’s stock valued at $218,000 after purchasing an additional 77 shares in the last quarter. Wedbush Securities Inc. increased its stake in Clorox by 1.2% in the 4th quarter. Wedbush Securities Inc. now owns 7,624 shares of the company’s stock valued at $1,238,000 after buying an additional 94 shares during the last quarter. Finally, Brooklyn Investment Group lifted its position in Clorox by 163.8% during the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock worth $25,000 after buying an additional 95 shares in the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Stock Up 2.4 %

Shares of CLX opened at $141.99 on Wednesday. The firm’s 50-day simple moving average is $146.19 and its 200 day simple moving average is $156.10. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.60 and a current ratio of 0.94. The firm has a market cap of $17.49 billion, a P/E ratio of 38.80, a price-to-earnings-growth ratio of 2.62 and a beta of 0.61. The Clorox Company has a 52 week low of $127.60 and a 52 week high of $171.37.

Clorox (NYSE:CLX – Get Free Report) last announced its earnings results on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, topping analysts’ consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same quarter last year, the company earned $2.16 EPS. On average, analysts forecast that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Wednesday, April 23rd will be paid a $1.22 dividend. The ex-dividend date is Wednesday, April 23rd. This represents a $4.88 annualized dividend and a dividend yield of 3.44%. Clorox’s dividend payout ratio (DPR) is presently 133.33%.

Wall Street Analyst Weigh In

CLX has been the topic of a number of recent research reports. DA Davidson lowered their target price on Clorox from $171.00 to $169.00 and set a “neutral” rating on the stock in a research report on Wednesday, February 5th. UBS Group lowered their price target on Clorox from $176.00 to $154.00 and set a “neutral” rating on the stock in a research report on Thursday, April 17th. JPMorgan Chase & Co. cut their price objective on Clorox from $173.00 to $151.00 and set a “neutral” rating for the company in a report on Friday, April 11th. Evercore ISI boosted their target price on shares of Clorox from $145.00 to $155.00 in a report on Tuesday, February 4th. Finally, Wells Fargo & Company cut their price target on shares of Clorox from $155.00 to $145.00 and set an “equal weight” rating for the company in a research note on Wednesday, April 16th. Three research analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has issued a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $153.83.

Get Our Latest Report on Clorox

About Clorox

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Read More

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).